
Yatharth Hospital & Trauma Care Services Q2 FY24 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 2
Margin
Category 3
Fundraise
N/A
Order
N/A
Capex
Yes
1 of 3 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 2- Revenue grew 36% YoY to ₹3,258 million in H1 FY24, with 34% YoY growth in Q2.
- Expect quarter-on-quarter top-line growth in coming quarters and years.
- Focus on increasing capacity utilization across existing hospitals except Noida, which is running high.
- Expansion plans to double bed capacity over 3-4 years via greenfield, brownfield, and acquisitions.
- Oncology services and robotic surgeries to commence in Q4 FY24, expected to boost revenues.
- International patient inflows from SAARC and CIS countries expected to grow significantly.
- Organ transplant and medical tourism businesses expanding, anticipated to improve ARPOB and revenues.
- New acquisitions (150-250 beds) planned before fiscal year-end to increase capacity and revenue.
- Noida extension and Greater Noida hospitals poised for strong catchment growth aiding revenue increase.
See what Yatharth Hospital & Trauma Care Services management said on margin guidance — free account, 30 seconds.
Fundraise plans
- The company is currently net debt-free as of September 2023, with a net cash position of ₹3,109 million, primarily from IPO proceeds.
- For the planned expansion, including addition of approximately 1,400-1,450 beds over the next three years, the company has Capex plans of around ₹800 crore.
- The company does not expect to require any long-term loan capital to fund these projects and is sufficiently funded for this expansion.
- No specific mention of new equity fundraising beyond the recently completed IPO.
- Focus remains on sustainable growth using existing funds without additional debt or equity raising at this point.
See what Yatharth Hospital & Trauma Care Services management said on order book — free account, 30 seconds.
Capex plans
Yes- Planned Capex of around ₹800 crore over the next three years for adding approximately 1,400-1,450 beds.
- Expansion includes both greenfield (new construction) and brownfield projects (expansion of existing facilities).
- Capex may vary depending on the proportion of beds added through O&M (Operations & Management) model versus greenfield construction.
- The company is sufficiently funded for this expansion, with no expected need for additional long-term loans.
- Acquired adjacent land parcels at Greater Noida hospital and Noida Extension hospital to support organic expansion.
- Expect first capacity increase through hospital acquisition (150-250 beds) to be completed by fiscal year-end.
- Expansion aimed at boosting specialties like oncology, organ transplants, and international patient business.
- Robotic surgery equipment will be commissioned soon as part of oncology service expansion.
Track Yatharth Hospital & Trauma Care Services — get its next earnings analysis in your feed
How does Yatharth Hospital & Trauma Care Services rank vs peers in Healthcare Services?
Pro featureHow does Yatharth Hospital & Trauma Care Services rank in Healthcare Services?
Compare Yatharth Hospital & Trauma Care Services against every Healthcare Services company (Q2 FY24) on revenue, margins and earnings-call signals.
Continue your research
What Yatharth Hospital & Trauma Care Services's management said in earlier quarters
Others in Healthcare Services this season
- Chandan Healthca (Q2 FY27)
Q2 FY27 operating income: ₹57.94 Cr, up 45.04% YoY from ₹39.95 Cr (Page 8) . Key investor presentation takeaways from Chandan Healthcare Ltd's Q2 FY27 investor
- Invicta Diagnostic (Q2 FY27)
Revenue from operations for the half year ended September 30, 2026: ₹379.11 lakhs (Page 4). Key results statement takeaways from Invicta Diagnostic Ltd's Q2 FY2
- Unihealth Hosp (Q2 FY27)
1,270 million with a year-on-year (YoY) growth of 6.3% . Key results statement takeaways from Unihealth Hospitals Ltd's Q2 FY27 results statement — and how it r
- Sangani Hospital (Q2 FY27)
1008.56 lakhs (~11.8% increase). Key results statement takeaways from Sangani Hospitals Ltd's Q2 FY27 results statement — and how it ranks against sector peers.